Yu H - Search Results

1

STAT proteins in cancer: orchestration of metabolism.

Li YJ, Zhang C, Martincuks A, Herrmann A, Yu H. Li YJ, et al. Among authors: yu h. Nat Rev Cancer. 2023 Mar;23(3):115-134. doi: 10.1038/s41568-022-00537-3. Epub 2023 Jan 3. Nat Rev Cancer. 2023. PMID: 36596870 Review.

2

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

Yu H, Kortylewski M, Pardoll D. Yu H, et al. Nat Rev Immunol. 2007 Jan;7(1):41-51. doi: 10.1038/nri1995. Nat Rev Immunol. 2007. PMID: 17186030 Review.

3

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.

Kujawski M, Kortylewski M, Lee H, Herrmann A, Kay H, Yu H. Kujawski M, et al. Among authors: yu h. J Clin Invest. 2008 Oct;118(10):3367-77. doi: 10.1172/JCI35213. J Clin Invest. 2008. PMID: 18776941 Free PMC article.

4

Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells.

Xin H, Zhang C, Herrmann A, Du Y, Figlin R, Yu H. Xin H, et al. Among authors: yu h. Cancer Res. 2009 Mar 15;69(6):2506-13. doi: 10.1158/0008-5472.CAN-08-4323. Epub 2009 Feb 24. Cancer Res. 2009. PMID: 19244102 Free PMC article.

5

Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy.

Kortylewski M, Kujawski M, Herrmann A, Yang C, Wang L, Liu Y, Salcedo R, Yu H. Kortylewski M, et al. Among authors: yu h. Cancer Res. 2009 Mar 15;69(6):2497-505. doi: 10.1158/0008-5472.CAN-08-3031. Epub 2009 Mar 3. Cancer Res. 2009. PMID: 19258507 Free PMC article.

6

Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors.

Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z, Forman S, Jove R, Pardoll DM, Yu H. Lee H, et al. Among authors: yu h. Cancer Cell. 2009 Apr 7;15(4):283-93. doi: 10.1016/j.ccr.2009.02.015. Cancer Cell. 2009. PMID: 19345327 Free PMC article.

7

In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses.

Kortylewski M, Swiderski P, Herrmann A, Wang L, Kowolik C, Kujawski M, Lee H, Scuto A, Liu Y, Yang C, Deng J, Soifer HS, Raubitschek A, Forman S, Rossi JJ, Pardoll DM, Jove R, Yu H. Kortylewski M, et al. Among authors: yu h. Nat Biotechnol. 2009 Oct;27(10):925-32. doi: 10.1038/nbt.1564. Epub 2009 Sep 13. Nat Biotechnol. 2009. PMID: 19749770 Free PMC article.

8

STATs in cancer inflammation and immunity: a leading role for STAT3.

Yu H, Pardoll D, Jove R. Yu H, et al. Nat Rev Cancer. 2009 Nov;9(11):798-809. doi: 10.1038/nrc2734. Nat Rev Cancer. 2009. PMID: 19851315 Free PMC article. Review.

9

The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors.

Hedvat M, Huszar D, Herrmann A, Gozgit JM, Schroeder A, Sheehy A, Buettner R, Proia D, Kowolik CM, Xin H, Armstrong B, Bebernitz G, Weng S, Wang L, Ye M, McEachern K, Chen H, Morosini D, Bell K, Alimzhanov M, Ioannidis S, McCoon P, Cao ZA, Yu H, Jove R, Zinda M. Hedvat M, et al. Among authors: yu h. Cancer Cell. 2009 Dec 8;16(6):487-97. doi: 10.1016/j.ccr.2009.10.015. Cancer Cell. 2009. PMID: 19962667 Free PMC article.

10

Antitumor activity of targeting SRC kinases in endothelial and myeloid cell compartments of the tumor microenvironment.

Liang W, Kujawski M, Wu J, Lu J, Herrmann A, Loera S, Yen Y, Lee F, Yu H, Wen W, Jove R. Liang W, et al. Among authors: yu h. Clin Cancer Res. 2010 Feb 1;16(3):924-35. doi: 10.1158/1078-0432.CCR-09-1486. Epub 2010 Jan 26. Clin Cancer Res. 2010. PMID: 20103658 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36,608 results

Search Page